Navigation Links
Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting

THE WOODLANDS, Texas--(BUSINESS WIRE)--Jun 11, 2007 - Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, made a poster presentation at the 2007 Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS) in San Diego June 7-11 at the Sheraton San Diego Hotel & Marina. The poster, entitled "Identifying New Immunodominant Myelin Peptides in Relapsing Remitting Multiple Sclerosis Patients" was presented on Sunday, June 10.

The presentation covered laboratory and clinical data from the Company's proprietary T-cell vaccination technology for the treatment of multiple sclerosis. Key highlights of research detailed in the poster presentation include:

-- Data accumulated from over 173 assays (using a T-cell Epitope Analysis Assay (EAA)) have allowed Opexa to identify several myelin protein peptides from myelin basic protein (MBP), myelin proteolipid protein (PLP) and myelin oligodendrocyte glycoprotein (MOG) as being immunodominant, including some peptides never before reported, and others as being non-reactive,

-- The EAA can be utilized to screen additional or combinations of peptides that have biological significance and;

-- These results have permitted Opexa to optimize the number of myelin peptides across the lengths of MBP, PLP and MOG in the screening assay for Tovaxin(TM) vaccine production to qualify subjects for Opexa's current 150-patient Phase IIb safety and efficacy clinical trial (TERMS).

"These findings mark an important development for Tovaxin, which is a patient-specific autologous T-cell vaccine, because it helps us qualify subjects for our current clinical trial and improves production of the vaccine. The EAA is an important assay for further refinement of the T-cell vaccination technology, which is truly personalized, to make the therapy as efficacious as possible for each patient," said
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Opexa Advances Monocyte Derived Islet Technology to Proof of Principle in stz-induced NOD/SCID Mice
2. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
3. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin for Multiple Sclerosis
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
6. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
7. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
8. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
9. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
10. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
11. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
Post Your Comments:
(Date:8/28/2014)... Aug. 28, 2014 Pharmatech initiated enrollment ... into this game-changing method for matching cancer patients ... clinical trials target specific cancers, disease staging, and ... for the cancer, in the first place. The ... information may not be well known to the ...
(Date:8/28/2014)... Aug. 28, 2014  In anticipation of the upcoming ... made available for the first time. Industry Overview: Medtech ... offers a snapshot of San Diego,s ... everything from the latest employment statistics to current venture capital ... San Diego such a vital part of the ...
(Date:8/28/2014)... Nonin Medical, Inc., the inventor of finger pulse oximetry ... that the Food and Drug Administration (FDA) has cleared ... use in the United States . ... or kiosk through a USB connector and measures oxygen ... The Model 3231 received EU certification last year. ...
Breaking Medicine Technology:Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... Va., Oct. 6 With October ... Association (NCPA) encourages community pharmacists to demonstrate their ... all aspects of medications, from dispensing to disposal. ... (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ...
... 6 Baxano, Inc. ( www.baxano.com ) today announced that ... Technology for Spine Care at the 2010 Spine Technology Awards. ... first place in the Best New Technology in Lumbar Care. ... 2010 Spine Technology Awards Gala in Orlando, FL. Baxano, Inc. ...
Cached Medicine Technology:NCPA Encourages Pharmacists to Promote Medication Expertise from Dispensing to Disposal 2NCPA Encourages Pharmacists to Promote Medication Expertise from Dispensing to Disposal 3Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards 2
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 "After reading ... who don’t stand very often, I decided that there needed ... periods during the day," said a concerned inventor from Sikestons, ... stand for long periods. It builds endurance and keeps the ... better health. Easy to use and producible in design variations, ...
(Date:8/29/2014)... Only a handful of CPR and basic life ... which are consistent with recent health guidelines, according ... Medicine Australasia , the journal for the Australasian ... recognition and treatment of sudden cardiac arrest are ... of Turkish emergency medicine specialists put together the ...
(Date:8/29/2014)... The Fresh Diet, America’s premier gourmet meal ... Vegetarian meal plan. Originating from The Fresh Diet’s commitment ... is designed to satisfy customers seeking a convenient, worry-free ... Responding to the growing demand by customers for non-meat ... (Forbes) with 14% of Americans identifying vegetarian meals as ...
(Date:8/29/2014)... Dennis Thompson HealthDay Reporter , ... during the early days of the Ebola outbreak in West ... mutates and spreads. Researchers report in the Aug. 28 ... determined the following: The Ebola strains responsible for ... to the very first recorded outbreak of Ebola in central ...
(Date:8/29/2014)... N.C (PRWEB) August 29, 2014 VHA ... awards for excellence in clinical care, honoring nine facilities ... the patient experience. , “At Novant Health, providing quality, ... top priority” said Tom Zweng, MD, executive vice president ... commitment to provide a remarkable experience for each and ...
Breaking Medicine News(10 mins):Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3Health News:Novant Health Recognized for Excellence in Clinical Care 2Health News:Novant Health Recognized for Excellence in Clinical Care 3
... U.S. wildfires are likely to increase in the coming ... the University of Comahue in Argentina and involving the ... outbreaks in the past five centuries with periods of ... ,States like Washington, Oregon, California, Colorado, New Mexico, Arizona ...
... appears that alcohol-induced bone loss resulting from excessive ... or the anti-osteoporosis drug Boniva? (ibandronate), a Loyola ... binge-alcohol drinking reduces bone mass, which is detrimental ... rate of bone loss in osteoporotic post-menopausal women,” ...
... new virus, a modified strain, has led to the death ... Five other pre mature babies are undergoing treatment. ... University Hospital after they were found to be carriers of ... aureus). ,Hospital authorities have confirmed that the baby ...
... Medicine, doctors report on the case of a 35 ... and emergency department //with double vision, slurred speech, drooping ... to be wound botulism. ,Wound botulism is a ... bacterium Clostridium botulinum contaminate a wound, germinate, and produce ...
... promises heavy investment opportunities for Non-Resident Keralites (NRK), making ... long term. ,Kerala Tourism Department has ... 23 – 27 for showcasing the opportunities in the ... a congregation of major hospitals, health insurance companies, policy ...
... approval for consumption of meat and milk from cloned animals ... and John C. Matheson. have declared that it is safe ... offspring. “On no basis can we differentiate the food products ... ,A formal recommendation will be released this week by ...
Cached Medicine News:Health News:New Study Links Western Wildfires to Atlantic Ocean Surface Temperatures 2Health News:New Study Links Western Wildfires to Atlantic Ocean Surface Temperatures 3Health News:Vitamin D or Anti-osteoporosis Drug Reduces Bone Loss from Binge Drinking 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: